Suchergebnisse - "Shimoyama, Tatsu"

PubPharm (127)

1

Secondary central nervous system involvement in patients with diffuse large B-cell lymphoma treated with rituximab combined CHOP therapy - a supplementary analysis of JCOG0601

enthalten in: Annals of hematology | 2024

von Shimada, K. | Ohmachi, K. | Machida, R. | +16

2

Secondary central nervous system involvement in patients with diffuse large B-cell lymphoma treated with rituximab combined CHOP therapy – a supplementary analysis of JCOG0601

enthalten in: Annals of hematology | 2024

von Shimada, K. | Ohmachi, K. | Machida, R. | +16

3

Clinical outcomes in transplant-eligible patients with relapsed or refractory diffuse large B-cell lymphoma after second-line salvage chemotherapy : A retrospective study

enthalten in: Cancer medicine | 2023

von Yagi, Y. | Kanemasa, Y. | Sasaki, Y. | +20

4

Hemoglobin-platelet index as a prognostic factor in patients with peripheral T-cell lymphoma

enthalten in: EJHaem | 2023

von Yagi, Y. | Kanemasa, Y. | Sasaki, Y. | +11

5

Long-term follow-up after R-High CHOP/CHASER/LEED with Auto-PBSCT in untreated mantle cell lymphoma-Final analysis of JCOG0406

enthalten in: Cancer science | 2023

von Ogura, M. | Yamamoto, K. | Morishima, Y. | +30

6

Utility of the frailty score for predicting prognosis and individualizing treatment intensity in elderly patients with diffuse large B cell lymphoma

enthalten in: Annals of hematology | 2023

von Yagi, Y. | Kanemasa, Y. | Sasaki, Y. | +11

7

Selection bias due to delayed comprehensive genomic profiling in Japan

enthalten in: Cancer science | 2023

von Tamura, T. | Ikegami, M. | Kanemasa, Y. | +11

8

Trastuzumab Deruxtecan in Anti-Human Epidermal Growth Factor Receptor 2 Treatment-Naive Patients With Human Epidermal Growth Factor Receptor 2-Low Gastric or Gastroesophageal Junction Adenocarcinoma : Exploratory Cohort Results in a Phase II Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Yamaguchi, K. | Bang, Y. | Iwasa, S. | +15

9

Current and future perspectives on CAR-T cell therapy to adult malignant lymphoma

enthalten in: Rinsho ketsueki] The Japanese journal of clinical hematology | 2023

von Shimoyama, T.

10

Polatuzumab vedotin, bendamustine, and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma, including the outcome as a bridging treatment to CAR-T cell therapy or allogeneic hematopoietic stem cell transplant

enthalten in: Rinsho ketsueki] The Japanese journal of clinical hematology | 2023

von Morita, Y. | Yagi, Y. | Kanemasa, Y. | +19

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]